Caroline Pot Kreis

34PUBLICATIONS
212CO-AUTHORS
AutoimmunityNeurology and neuromuscular diseasesGene and molecular therapyEconomic models and forecastingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 22, 2026
Anti-CD20 B cell depletion is associated with elevated mucosal-originating circulating regulatory IgA B cells in multiple sclerosis.

|Apr 23, 2026
Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.

|Jan 22, 2026
[Neurology : what's new in 2025].

Andria Tziakouri, Valentin Loser, Alex Vicino

|Dec 26, 2025
Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controls.

Eline A J Willemse, Sofia Sandgren, Pascal Benkert

|Dec 15, 2025
Chemotherapy-driven intestinal dysbiosis and indole-3-propionic acid rewire myelopoiesis to promote a metastasis-refractory state.

Ludivine Bersier, L Francisco Lorenzo-Martin, Yi-Hsuan Chiang

|Nov 14, 2025
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.

Aleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler

Pageof 6

Frequent Collaborators

12 joint publications

Cristina Granziera

11 joint publications

Pascal Benkert

11 joint publications

Jens Kuhle

10 joint publications

Claudio Gobbi